EMA starts evaluating the use of Kineret in adult COVID-19 patients at increased risk of severe…
EMA has started evaluating an application to extend the use of Kineret (anakinra) to include treatment of coronavirus disease 2019 (COVID-19) in adult patients with pneumonia who are at risk of developing severe respiratory failure…